Who actually is ICRC-Weyer? ICRC-Weyer is a medium-sized CRO with >25 employees and three decades of company experience.
What makes ICRC-Weyer particularly attractive for its customers? The mixture of well-trained and flexible young employees in combination with “old hands” in the CRO business. According to our company motto: “Small enough to care, big enough to cope.”, our employees dedicate themselves to all our customers’ orders with high motivation and commitment.
In which areas is ICRC-Weyer active? We support our customers in the areas of clinical studies and medical device development, IIT and NIS as well as pre- and post-marketing safety and pharmaco¬vigilance writing. Due to the high number of experts from different fields of science and specific background we also provide consulting for our clients to find the way into calm waters for them.
Where is ICRC-Weyer located? The company is headquartered in Berlin (Germany). A capital and cluster region where a lot of big players in the CRO industry and important clients are located.
What is the main focus of ICRC-Weyer? A focus of our customers is the implementation of clinical studies in the field of biostatistics and data management — including first in human (FIH) studies, dose finding, pharmacokinetics, proof of concept (PoC) as well as more complex clinical studies with an international approach in many therapeutic areas until and after admission to the market.
Our company has a special focus on safety and pharmacovigilance writing, as well as analysis and reporting also for complex clinical studies in close connection with global players in the pharma market.
Who is part of the ICRC-Weyer customer base? Global players, medium-sized companies but also new start-ups and Academia/academic researchers.
What makes ICRC-Weyer attractive as an employer? Our employees benefit from working on a variety of different studies in a multinational team with sense for fresh ideas in close cooperation with very experienced colleagues, who are happy to share their rich knowledge. In this way all our employees can quickly gain experience in the CRO market, while making meaningful, independent contributions right from the start. We are all aware of the positive effects of workplace diversity and actively live and configure it.
Dr. Joachim Kind, Director Biostatistics & Data Management